You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
微创医疗(00853.HK)附属引入中金(03908.HK)等投资者 涉资逾1.5亿美元
阿思达克 11-11 09:23
微创医疗(00853.HK)公布,其目标公司Microport NeuroTech获六名投资者认购共约203.25万股新发行A轮优先股,总代价约3,126万美元;另附属公司MicroPort Scientific Investment向该等投资者转让目标公司约772.04万股普通股,代价约1.19亿美元。完成后,目标公司所转让普通股将重新分类及重新指定为A轮优先股,而目标公司投资后估值将达约17.5亿美元。 目标公司于香港、英属处女群岛及中国设有附属,其主要从事神经血管疾病(包括出血性卒中、脑动脉粥样硬化及急性缺血性卒中)的治疗及通路类医疗器械的研发、制造及商业化。 该6名投资者包括中金公司(03908.HK)、HHF Group、BVF III(BVI) Holding L.P.、Biolink Healthcare Investment、Star Wave Ventures及Always Enterprises。于该等交易完成及转换可换股债券后,该6名投资者合共持有目标公司约8.57%股权,至于附属公司的持股量由69.89%降至54.64%。 公司认为,是次增资及引入新投资者将为目标集团带来进一步加强其产品研发和市场开拓所需的资金,从而有助于目标集团更好地提升其市场竞争力、拓宽市场资源,并促进快速发展,亦有利于进一步提升集团的品牌影响力及市场价值。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account